Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.23.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]        
Revenues, net of slotting and promotion $ 10,605 $ 127,173 $ 103,944 $ 321,000
Operating expenses        
Cost of product sold 58,474 146,766 225,591 359,745
Advertising and promotional 38,960 218,820 129,295 684,611
Selling, general and administrative expense 155,075 36,193 385,711 381,146
Professional fees (96,850) 58,867 744,547 541,036
Total operating expenses 155,659 460,646 1,485,144 1,966,538
Loss from operations 145,054 333,473 1,381,200 1,645,538
Other (income) and expenses        
Interest expense – debt 40,758 21,661 98,086 26,570
Interest expense – financing cost (1,696,970) 1,813,940 270,210
Amortization of debt discount 132,805 1,162,257 90,852
(Gain) loss on debt extinguishment 392,459 78,634 319,995
Other expense- non cash 15,192
Total other (income) expense (1,130,948) 100,295 3,394,278 402,824
Provision for income tax
Net Income (Loss) 985,893 (433,768) (4,775,478) (2,048,362)
Deemed dividend on Series B Preferred Stock (2,565,151) 1,120,514 358,657
Net loss attributable to common shareholders $ 3,551,044 $ (433,768) $ (5,895,993) $ (2,407,019)
Basic and diluted net loss per common share (in Dollars per share) $ 0.03 $ 0 $ (0.06) $ (0.03)
Weighted average shares of capital outstanding – basic and diluted (in Shares) 105,672,769 89,725,839 98,556,215 90,899,831